(S)-Coclaurine

CAS No. 486-39-5

(S)-Coclaurine( —— )

Catalog No. M29119 CAS No. 486-39-5

(S)-Coclaurine is an antagonist of nAChR isolated from Sarcopetalum harveyanum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 306 Get Quote
10MG 506 Get Quote
25MG 1048 Get Quote
50MG 1571 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (S)-Coclaurine
  • Note
    Research use only, not for human use.
  • Brief Description
    (S)-Coclaurine is an antagonist of nAChR isolated from Sarcopetalum harveyanum.
  • Description
    (S)-Coclaurine is an antagonist of nAChR isolated from Sarcopetalum harveyanum.(In Vitro):(+)-R-Coclaurine shows negative inotropic effects. Coclaurine derivatives and of paeoniflorin derivatives have neuromuscular blocking actions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    486-39-5
  • Formula Weight
    285.343
  • Molecular Formula
    C17H19NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc2CCN[C@@H](Cc3ccc(O)cc3)c2cc1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • VU 0255035

    VU 0255035 is a highly selective, competitive and brain penetrant muscarinic M1 receptor antagonist with an IC50 of 130 nM.

  • GSK233705

    GSK233705 (Darotropium bromide) is a muscarinic receptor antagonist used in conjunction with the prevention and treatment of chronic obstructive pulmonary disease (COPD) and asthma in humans.

  • Darifenacin

    Darifenacin (UK-88525) is a muscarinic receptor M3 antagonist with anticonvulsant activity and can be used to study urinary incontinence and overactive bladder.